Pramipexole dihydrochloride

An enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist an antioxidant that targets mitochondria to prevent apoptosis.

An enantiomer of pramipexole that is ~100-fold less active than the (S) form as a dopamine receptor agonist an antioxidant that targets mitochondria to prevent apoptosis.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Anti-CDR2 cerebellar degeneration-related protein 2, 62kDa,

Anti-CDR2 cerebellar degeneration-related protein 2, 62kDa,

Anti-CDR2 cerebellar degeneration-related protein 2, 62kDa,

Anti-CDR2 cerebellar degeneration-related protein 2, 62kDa,

Anti-GDAP1 ganglioside induced differentiation associated pr

Anti-PTGDS prostaglandin D2 synthase 21kDa (brain), 100ul UN

Immunogen Synthetic peptide directed towards the N terminal region of human SMPD2 Application Anti-SMPD2 antibody produced in rabbit is suitable for western blotting at a concentration of 1.25&#956g/ml.

Immunogen Synthetic peptide directed towards the N terminal region of human SMPDL3B Biochem/physiol Actions Located on chromosome 1, this gene encodes for acid sphingomyelinase-like phosphodiesterase 3b precursor protein. Sequence Synthetic peptide

BAY 73-6691 ((R)-BAY 73-6691) is a potent, brain penetrant, and selective PDE9A inhibitorIn VitroThe BAY 73-6691 dose-dependently alleviates cell viability loss due to Aβ 25-35 treatment. It is found that when SH-SY5Y cells are cultured by Aβ 25-35